Icu Medical annual ebitda margin
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Icu Medical EBITDA Margin Growth & History (ICUI)
Icu Medical's ebitda margin was 10.92% for fiscal 2025.
View full Icu Medical company overviewIcu Medical annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 10.92% | −0.10 pp |
| 2024 | 2024-12-31 | 11.02% | −0.12 pp |
| 2023 | 2023-12-31 | 11.14% | +2.70 pp |
| 2022 | 2022-12-31 | 8.43% | −7.75 pp |
| 2021 | 2021-12-31 | 16.18% | +1.72 pp |
| 2020 | 2020-12-31 | 14.46% | −0.09 pp |
| 2019 | 2019-12-31 | 14.55% | +7.09 pp |
| 2018 | 2018-12-31 | 7.46% | +3.34 pp |
| 2017 | 2017-12-31 | 4.12% | −22.76 pp |
| 2016 | 2016-12-31 | 26.88% | +1.53 pp |
| 2015 | 2015-12-31 | 25.36% | +6.45 pp |
| 2014 | 2014-12-31 | 18.91% | −3.87 pp |
| 2013 | 2013-12-31 | 22.78% | −2.56 pp |
| 2012 | 2012-12-31 | 25.33% | −2.30 pp |
| 2011 | 2011-12-31 | 27.64% | +4.66 pp |
| 2010 | 2010-12-31 | 22.97% | +0.66 pp |
| 2009 | 2009-12-31 | 22.32% | +0.04 pp |
| 2008 | 2008-12-31 | 22.28% | +2.90 pp |
| 2007 | 2007-12-31 | 19.37% | — |
Icu Medical quarterly ebitda margin
Q1.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 16.09% | +5.11 pp |
| Q1 2026 | 2026-03-31 | 12.00% | +1.69 pp |
| Q4 2025 | 2025-12-31 | 10.44% | −3.96 pp |
| Q3 2025 | 2025-09-30 | 12.02% | +1.17 pp |
| Q2 2025 | 2025-06-30 | 10.98% | +0.41 pp |
| Q1 2025 | 2025-03-31 | 10.31% | +2.39 pp |
| Q4 2024 | 2024-12-31 | 14.40% | +6.75 pp |
| Q3 2024 | 2024-09-30 | 10.85% | −3.83 pp |
| Q2 2024 | 2024-06-30 | 10.56% | −0.41 pp |
| Q1 2024 | 2024-03-31 | 7.92% | −3.54 pp |
| Q4 2023 | 2023-12-31 | 7.65% | −2.14 pp |
| Q3 2023 | 2023-09-30 | 14.68% | +4.95 pp |
| Q2 2023 | 2023-06-30 | 10.97% | −0.89 pp |
| Q1 2023 | 2023-03-31 | 11.46% | +9.43 pp |
| Q4 2022 | 2022-12-31 | 9.79% | −4.00 pp |
| Q3 2022 | 2022-09-30 | 9.73% | −8.31 pp |
| Q2 2022 | 2022-06-30 | 11.86% | −5.75 pp |
| Q1 2022 | 2022-03-31 | 2.02% | −13.30 pp |
| Q4 2021 | 2021-12-31 | 13.79% | −1.38 pp |
| Q3 2021 | 2021-09-30 | 18.04% | +3.29 pp |
| Q2 2021 | 2021-06-30 | 17.61% | +4.03 pp |
| Q1 2021 | 2021-03-31 | 15.32% | +1.01 pp |
| Q4 2020 | 2020-12-31 | 15.17% | +3.22 pp |
| Q3 2020 | 2020-09-30 | 14.75% | −2.19 pp |
| Q2 2020 | 2020-06-30 | 13.57% | −0.85 pp |
| Q1 2020 | 2020-03-31 | 14.31% | −0.63 pp |
| Q4 2019 | 2019-12-31 | 11.95% | +8.86 pp |
| Q3 2019 | 2019-09-30 | 16.94% | +10.39 pp |
| Q2 2019 | 2019-06-30 | 14.42% | +0.74 pp |
| Q1 2019 | 2019-03-31 | 14.94% | +8.70 pp |
| Q4 2018 | 2018-12-31 | 3.10% | −13.76 pp |
| Q3 2018 | 2018-09-30 | 6.55% | +2.49 pp |
| Q2 2018 | 2018-06-30 | 13.68% | +19.00 pp |
| Q1 2018 | 2018-03-31 | 6.24% | +8.42 pp |
| Q4 2017 | 2017-12-31 | 16.85% | −2.45 pp |
| Q3 2017 | 2017-09-30 | 4.05% | −23.92 pp |
| Q2 2017 | 2017-06-30 | −5.32% | −33.87 pp |
| Q1 2017 | 2017-03-31 | −2.18% | −34.17 pp |
| Q4 2016 | 2016-12-31 | 19.30% | +0.15 pp |
| Q3 2016 | 2016-09-30 | 27.97% | −5.76 pp |
| Q2 2016 | 2016-06-30 | 28.55% | −0.95 pp |
| Q1 2016 | 2016-03-31 | 31.99% | +12.84 pp |
| Q4 2015 | 2015-12-31 | 19.15% | −1.95 pp |
| Q3 2015 | 2015-09-30 | 33.72% | +16.44 pp |
| Q2 2015 | 2015-06-30 | 29.50% | +12.22 pp |
| Q1 2015 | 2015-03-31 | 19.15% | −0.85 pp |
| Q4 2014 | 2014-12-31 | 21.10% | −2.78 pp |
| Q3 2014 | 2014-09-30 | 17.28% | −7.21 pp |
| Q2 2014 | 2014-06-30 | 17.28% | −2.84 pp |
| Q1 2014 | 2014-03-31 | 19.99% | −2.53 pp |
| Q4 2013 | 2013-12-31 | 23.88% | −4.61 pp |
| Q3 2013 | 2013-09-30 | 24.49% | −2.86 pp |
| Q2 2013 | 2013-06-30 | 20.12% | −3.56 pp |
| Q1 2013 | 2013-03-31 | 22.53% | +1.13 pp |
| Q4 2012 | 2012-12-31 | 28.49% | −11.20 pp |
| Q3 2012 | 2012-09-30 | 27.34% | +3.90 pp |
| Q2 2012 | 2012-06-30 | 23.68% | −0.14 pp |
| Q1 2012 | 2012-03-31 | 21.40% | −1.98 pp |
| Q4 2011 | 2011-12-31 | 39.69% | +13.84 pp |
| Q3 2011 | 2011-09-30 | 23.44% | −1.49 pp |
| Q2 2011 | 2011-06-30 | 23.82% | +0.72 pp |
| Q1 2011 | 2011-03-31 | 23.38% | +6.27 pp |
| Q4 2010 | 2010-12-31 | 25.85% | +6.83 pp |
| Q3 2010 | 2010-09-30 | 24.93% | +3.47 pp |
| Q2 2010 | 2010-06-30 | 23.10% | −0.20 pp |
| Q1 2010 | 2010-03-31 | 17.11% | −9.17 pp |
| Q4 2009 | 2009-12-31 | 19.02% | — |
| Q3 2009 | 2009-09-30 | 21.46% | −4.49 pp |
| Q2 2009 | 2009-06-30 | 23.30% | — |
| Q1 2009 | 2009-03-31 | 26.28% | +12.72 pp |
| Q3 2008 | 2008-09-30 | 25.95% | — |
| Q1 2008 | 2008-03-31 | 13.56% | — |
Icu Medical ebitda margin trends
Over the last five fiscal years, Icu Medical's ebitda margin decreased from 14.46% to 10.92%, a change of −3.54 percentage points. The latest reported quarter, Q2 2026, shows 16.09%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Icu Medical source filings ↗